{"favorite_id": 1786, "calc_type": "", "dosing": false, "full_title_en": "RIETE Score for Risk of Hemorrhage in Pulmonary Embolism Treatment", "short_title_en": "RIETE Score", "medium_description_en": "Determine the risk of major bleeding during anticoagulant therapy.", "short_description_en": "Bleeding risk from PE anticoagulation.", "before_use": "", "instructions_en": "", "purpose_en": ["Prognosis"], "disease_en": ["Pulmonary Embolism"], "specialty_en": ["Cardiology", "Critical Care", "Emergency Medicine", "Hematology and Oncology", "Hospitalist Medicine", "Pulmonology"], "chief_complaint_en": ["Chest Pain", "Shortness of Breath"], "system_en": ["Cardiac", "Hematologic", "Respiratory"], "search_abbreviation_en": ["pulm", "reite", "pe", "lovenox", "coumadin", "warfarin"], "slug": "riete-score-risk-hemorrhage-pulmonary-embolism-treatment", "seo": {"meta_description_en": "The RIETE Score for Risk of Hemorrhage in PE Treatment determines the risk of major bleeding during anticoagulant therapy for pulmonary embolism.", "keywords_en": "bleeding complication, RIETE calculator, RIETE bleeding, bleeding anticoagulation, major bleeding risk, RIETE registry, RIETE, pulmonary embolism bleeding risk, PE bleeding risk, PE hemorrhage risk, PE treatment risk"}, "content": {"how_to_use": {"use_case_en": "<p>Consider using the RIETE score to stratify patients\u2019 risk for bleeding after anti-coagulation for DVT/PE in conjunction with situation specific risks/benefits.</p>", "pearls_pitfalls_en": "<p>The RIETE registry developed a clinical score to stratify a patient\u2019s risk of major bleeding with anticoagulation for DVT or PE.</p> <ul> <li>Included all patients with symptomatic acute DVT or PE diagnosed by CTV or US for DVT and pulmonary angiography, lung scintigraphy or helical CT for PE</li> <li>Scoring system consisted of 6 criteria, 1 of which was worth 2 points, 2 worth 1.5 points each, and 3 worth 1 point each</li> <li>The study used 0 points to define low risk for major bleeding events (0.1% risk of bleeding), 1-4 points for intermediate risk (2.8% risk), and &gt;4 points for high risk (6.2% risk)</li> <li>Major bleeding was defined as overt bleeding plus one of the following: <ul> <li>Required transfusion of 2+ units of blood,</li> <li>Retroperitoneal, spinal or intracranial, OR</li> <li>Fatal</li> </ul> </li> </ul> <p><strong>Points to keep in mind:</strong></p> <ul> <li>Study used same population for derivation and validation cohorts</li> <li>Did not distinguish between different types of anticoagulation</li> <li>Anemia was never defined</li> <li>Score has not been externally validated. The only validation study to date utilized the same RIETE database and used a different endpoint.</li> </ul> <p>A subsequent risk score has been developed by the <calculator id='1718'>ATRIA</calculator> group which also used similar criteria in their score to determine risk of bleeding after anti-coagulation with warfarin for atrial fibrillation. They also had a similar overall bleeding rate as the RIETE group.</p>", "why_use_en": "<p>The RIETE score is based on a very large cohort of patients and, if validated, has a significant difference in outcomes between the low and high risk groups, making it a potentially powerful tool to guide the decision to anticoagulate.</p> "}, "next_steps": {"advice_en": "", "management_en": "", "critical_actions_en": "<ul> <li>Risks and benefits of anti-coagulation should be carefully considered in ALL patients prior to initiating therapy</li> <li>Alternative options should often be considered in patients with high-risk of major bleeding events in need of anti-coagulation</li> </ul> "}, "about": {"formula_en": "<p>Addition of the selected points, see below:</p>", "more_info_en": "<div class='table-responsive'> <table class='table table-bordered'> <tbody> <tr> <th>Risk Factor</th> <th>Point Value</th> </tr> <tr> <td>Recent Major Bleeding</td> <td>2</td> </tr> <tr> <td>Cr &gt; 1.2 mg/dL</td> <td>1.5</td> </tr> <tr> <td>Anemia</td> <td>1.5</td> </tr> <tr> <td>Cancer</td> <td>1</td> </tr> <tr> <td>Clinically-overt PE</td> <td>1</td> </tr> <tr> <td>Age &gt;75</td> <td>1</td> </tr> </tbody> </table> </div>", "evidence_based_medicine_en": "", "references_list": {"Original/Primary Reference": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/18612534", "text": "Ru\u00edz-Gim\u00e9nez N, Su\u00e1rez C, Gonz\u00e1lez R, Nieto JA, Todol\u00ed JA, Samperiz AL, Monreal M; RIETE Investigators. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry.Thromb Haemost. 2008 Jul;100(1):26-31. doi: 10.1160/TH08-03-0193."}], "Other References": [], "Validation": [{"href": "http://www.ejinme.com/article/S0953-6205(08)00032-0/abstract", "text": "Guijarro, Ricardo et al. Venous thromboembolism in Spain. Comparison between an administrative database and the RIETE registry. European Journal of Internal Medicine , Volume 19 , Issue 6 , 443 - 446."}], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": [{"description": "<p>Calvin Hwang, MD, is a clinical assistant professor in the department of orthopaedic surgery at the Stanford University School of Medicine. A native Californian, Dr. Hwang grew up in San Diego and attended Stanford University before venturing off to Case Western Reserve University School of Medicine, where he received his medical degree. He completed his residency at the Stanford/Kaiser Emergency Medicine program and fellowship in sports medicine at Stanford. He is currently a team physician for the Golden State Warriors, Stanford Football and Stanford Volleyball.</p>", "firstName": "Calvin", "img": "calvin-hwang.jpg", "lastName": "Hwang", "name": "Calvin Hwang, MD", "target": "calvin-hwang", "signedCOI": true, "hasDisclosure": []}]}, "creator": [{"name": "Dr. Nuria Ru\u00edz-Gim\u00e9nez Arrieta", "qa_en": "", "approved": false, "creator_info": {"about_en": "<p>Nuria Ru\u00edz-Gim\u00e9nez Arrieta, MD, practices internal medicine at Hospital Universitario de La Princesa, Madrid, Spain. She is also an associate professor at the Universidad Aut\u00f3noma de Madrid. Dr. Arrieta\u2019s research interests include venous thromboembolism and geriatrics. </p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-nuria-rui%CC%81z-gime%CC%81nez-arrieta.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Ru%C3%ADz-Gim%C3%A9nez+N%5BAuthor%5D"}}], "reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "toggle", "label_en": "Recent major bleeding", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 2}], "name": "major_bleeding"}, {"type": "toggle", "label_en": "Creatinine >1.2 mg/dL (106 \u00b5mol/L)", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1.5}], "name": "creatinine"}, {"type": "toggle", "label_en": "Anemia", "default": 0, "conditionality": "", "show_points": true, "tips_en": "Hgb <13 g/dL for men, Hgb <12 g/dL for women", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1.5}], "name": "anemia"}, {"type": "toggle", "label_en": "Malignancy history", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "malignancy"}, {"type": "toggle", "label_en": "Clinically-overt pulmonary embolism", "default": 0, "conditionality": "", "show_points": true, "tips_en": "Patients who were evaluated for PE and PE diagnosed, NOT incidental PE found during other studies", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "pulmonary_embolism"}, {"type": "toggle", "label_en": "Age >75", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "age_75"}], "md5": "", "cmeReleaseDate": null, "cmeEndDate": null, "cmeLastReviewed": null, "cmeVersion": "1786.1", "related_calcs": [{"calcId": 1718, "short_title_en": "ATRIA Bleeding Risk", "slug": "atria-bleeding-risk-score"}, {"calcId": 1247, "short_title_en": "Simplified PESI", "slug": "simplified-pesi-pulmonary-embolism-severity-index"}, {"calcId": 1304, "short_title_en": "PESI Score", "slug": "pulmonary-embolism-severity-index-pesi"}]}